Skip to content
Subscriber Only

J&J to Pay $117 Million in Nationwide Pact Over Vaginal Mesh

  • Attorneys general argued J&J, Ethicon unit misrepresented risk
  • Companies still face 25,000 consumer lawsuits over product
J&J Pitches $4 Billion for Opioids as Distributors Seek Deal

Photographer: Scott Eells/Bloomberg

Updated on

Johnson & Johnson agreed to pay $117 million to settle 41 states’ claims that it misrepresented the risks of vaginal-mesh products used to bolster sagging organs and treat incontinence in women.

A group of state attorneys general argued after an investigation that marketing by J&J and its Ethicon unit misrepresented the safety of the device, which is alleged to damage organs and leave women in constant pain, according to Ohio Attorney General David Yost.